Interaction of Human Papillomavirus (Hpv) Type-16 Capsid Proteins with Hpv Dna Requires An Intact L2 N-Terminal Sequence by Zhou, Jian et al.
JOURNAI OF VIROLOGY, Feb. 1994, P. 619-625 Vol. 68, No. 2
0022-538X/94/$04.00+0
Copyright © 1994, American Society for Microbiology
Interaction of Human Papillomavirus (HPV) Type 16 Capsid
Proteins with HPV DNA Requires an Intact
L2 N-Terminal Sequence
JIAN ZHOU, XIAO-YI SUN, KYLIE LOUIS, AND IAN H. FRAZER*
Papillomavirus Research Unit, University of Queensland, Prinicess Alexandra Hospital,
Woolloongabba, Queensland 4102, Australia
Received 23 August 1993/Accepted 20 October 1993
Encapsidation of papillomavirus DNA involves DNA-protein and protein-protein interactions. We sought to
define the role of each human papillomavirus (HPV) capsid protein in HPV DNA encapsidation. HPV16 major
(Li) and minor (L2) capsid proteins purified from recombinant vaccinia virus-infected cells were compared for
their ability to bind nucleic acids. L2 protein, but not LI protein, could bind HPV DNA. To map the
DNA-binding region of L2, a series of truncated or point-mutated L2 protein open reading frames were used
to show that only the N terminal of L2 was required for L2-DNA binding. This interaction depends critically
on charged amino acids (Lys or Arg) in the first 12 amino acids of the N terminal of the protein. Several
techniques were used to show that L2 interaction with DNA did not require specific DNA sequences. We
propose that HPV L2 protein may play a major role in papillomavirus capsid assembly by introducing HPV
DNA to the virus particles formed by the self assembly of the LI major structural protein.
Human papillomaviruses (HPVs) are a family of small DNA
viruses which induce benign hyperproliferative lesions of the
cutaneous and mucosal epithelia. Of the 70 different virus
types which have been identified, more than 20 are associated
with anogenital lesions (9). Regulatory signals for HPV DNA
replication and for transcription have been analyzed in great
detail (4, 6). However, studies on papillomavirus (PV) virion
assembly and PV DNA encapsidation are limited because no
tissue culture system readily supports PV propagation and
because lesions associated with infection with HPV16, the
major genotype associated with anogenital malignancy (40),
contain few PV particles and low levels of viral structural
proteins.
PV capsids comprise two virally encoded structural proteins,
designated LI and L2, which are assembled onto a DNA-
protein complex (13). A single virus capsid is a T=7d icosahe-
dron composed of 72 pentameric capsomeres, each of which
contains five molecules of the major capsid protein, LI (1, 12).
The minor capsid protein, L2, is present at approximately 1/10
the abundance of LI (10) and has an unknown structural role.
LI protein is directed to the nucleus by a C-terminal nuclear
localization signal (36); virus assembly occurs in the nucleus
(28, 29). Recombinant LI protein self-assembles into particles
resembling virus capsids (37), but assembly is enhanced in the
presence of L2 protein, which may be required for assembly of
infectious virions (15, 39).
As a step toward the definition of the mechanism of PV
assembly and of encapsidation of the viral minichromosome,
we characterized the interaction of each of the capsid proteins
of HPV16 with nucleic acid by using purified LI and L2
proteins expressed from recombinant vaccinia viruses (rVV).
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MATERIALS AND METHODS
Plasmid construction. For expression in VV, the open
reading frame corresponding to the 474-amino-acid HPV16L2
coding region was amplified by PCR from a plasmid containing
the HPV16 genome. The 5' primer introduced a BamHI site
upstream from the L2 open reading frame ATG, and the 3'
primer introduced a SmaI site beyond the termination codon.
The amplified L2 fragment was recovered by elution from an
agarose gel, cut with BamHI and Smal, and ligated into
plasmid RK19 (16), creating RK19/16L2, in which L2 expres-
sion is driven by the VV late promoter 4b. The HPV16L2 and
4b promoter were then transferred to the VV expression
vector pSX3 (39) for rVV construction.
To create the simplified vector pUCI8/4bl6L2 and facilitate
transfer of mutant L2 genes between vectors used for VV
expression, a Klenow-blunted MluI-EcoRI fragment carrying
the VV 4b promoter and the whole HPV16L2 open reading
frame was cleaved from RK19/16L2 and inserted into pUC18.
This plasmid was used as the DNA template for PCR ampli-
fications with primers designed to create C-terminal trunca-
tions of L2. Mutants A374, A384, A394, A404, and A414,
C-terminally truncated to residues 374, 384, 394, 404, and 414
of the L2 protein, respectively, were created by using a
common 5' primer (M13RSP) (36) and a panel of 3' primers
introducing stop codons (TAA) at codons 374, 384, 394, 404,
and 414. To create N-terminal truncation and point mutations,
we used a panel of 5' primers. N-terminal deletions (Al-2,
A1-3, A1-4, A1-5, A1-6, A1-7, A1-8, A1-9, Al-10, Al-ll,
Al-12, A1-13, Al-14, Al-15, Ai-20, AI-40, Al-60, Al-80,
and AI-100) were created by using the set of primers which
introduced ATG codons at positions corresponding to amino
acids 2, 3, 4,5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 20, 40, 60, 80, and
100, respectively. For N-terminal point mutations (designated
H3P; K4P; 2,4,5,N; R5P; S6N; S6P; A7P; K8P; R9P; and 8,9N),
amino acids 3, 4, 5, 6, 7, 8, and 9 were changed to either proline
(Pro) or asparagine (Asn) by the mismatched-primer method
(36). All mutations were confirmed by direct sequencing of the
expression plasmids.
Cells and virus. CV-1 cells were maintained in Dulbecco's
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modified Eagle's medium (GIBCO) supplemented with 10%
fetal or newborn bovine serum (CSL, Melbourne, Australia).
Plaque-purified isolates of rVVs were propagated in CV-1 cells
grown in Dulbecco's modified Eagle's medium supplemented
with 2.5% fetal bovine serum.
rW construction. We used previously described methods(39) for rVV construction. Briefly, plasmids including the
HPV16L2 gene with various mutations driven from the VV
late promoter 4b, the Escherichia coli gpt gene (7, 11) as a
selectable marker, and flanking fragments of the VV B24R
gene (18, 31) or thymidine kinase (TK) gene were transfected
into VV WR strain-infected (0.05 PFU per cell) CV-1 cells by
calcium phosphate precipitation. Virus plaques were purified
twice in CV-1 cells in the presence of mycophenolic acid at a
concentration of 25 pg/ml.
Immunoprecipitation of Li and L2 proteins. CV-1 cells
were infected with HPV16L1 rVV or HPV16L2 rVV at a
multiplicity of infection of about 20 PFU per cell. At 48 h, 5 x
105 infected cells were lysed with RIPA buffer (150 mM NaCl,
1% Nonidet P-40, 0.5% deoxycholate, 0.1% sodium dodecyl
sulfate [SDS], 50 mM Tris [pH 8.0]). Lysed cells were centri-
fuged briefly at 12,000 x g, and the supernatant was used for
immunoprecipitation. Immunoprecipitation were carried out
with a 1:20 dilution of monoclonal anti-HPV16L1 antibody(24) or a 1:2,000 dilution of rabbit anti-HPV16L2 antibody(provided by D. A. Galloway). The precipitated Li or L2
protein was collected with protein A-Sepharose beads and
washed four times in RIPA buffer. Proteins were removed
from protein A-Sepharose beads by boiling in polyacrylamide
gel electrophoresis (PAGE) sample buffer and separated by
SDS-PAGE for analysis.
Southwestern assays. The Southwestern (DNA-protein) as-
says were based on previously published procedures (23, 26).
Immunoprecipitated HPV16L1 and HPV16L2 proteins were
separated on a SDS-10% polyacrylamide gel and transferred
to a nitrocellulose filter by electroblotting. Filters were blocked
with blocking buffer (10 mM Tris [pH 7.5], 5% nonfat skim
milk, 10% glycerol, 2.5% Nonidet P-40, 0.1 mM dithiothreitol[DTT], 150 mM NaCl) at 4°C for 12 h. The filters were then
washed with binding buffer (10 mM Tris [pH 7.5], 40 mM
NaCl, 1 mM EDTA, 1 mM DTT, 8% glycerol, 0.125% skim
milk). 32P-labeled probes were added to binding buffer, and
incubation was continued for 4 h at 4°C. The filters were
washed with five changes of binding buffer. After being air
dried, they were wrapped and exposed to X-ray films. They
were subsequently reprobed with anti-HPV16L1 or anti-
HPV16L2 antiserum and 125I-protein A to confirm protein
transfer.
Binding specificity assay. DNA sequences binding specifi-
cally to L2 were selected from a pool of double-stranded,
76-mer oligonucleotides (R76) containing a central stretch of
26 random base pairs, flanked by two unique sequences of 25
bp each (33). The sequences of these oligonucleotides were
R76 5'-
CAGGTCAGATCAGCGGATCCTGTCG (N) 26GAGGCGAATTCAGTGCATGTGCAGC -3'
Forward primer 5' -GCTGCACATGCACTGAATTCGCCTC-3'
Back primer 5'-CAGGTCAGATCAGCGGATCCTGTCG-3'
Random oligonucleotide-binding assays were performed es-
sentially as described previously (34). Briefly, Li and L2
proteins purified by immunoprecipitation were electropho-
resed on an SDS-PAGE gel (10% polyacrylamide) and trans-
ferred to a nitrocellulose filter. Filters were incubated for 4 h
at 4°C in buffer A (20 mM N-2-hydroxyethylpiperazine-N'-2-
ethanesulfonic acid [HEPES]-HCl [pH 7.9], 1 mM DTT, 10%
glycerol, 0.01% Nonidet P-40) containing 50 mM KCl and 5%
skim milk. The 32P-labeled pool of random oligonucleotides
was prepared by primed synthesis with the forward primer
annealed to the random 76-mer oligonucleotide template,
added to the filter, and incubated overnight at 4°C. Washes
were performed at 4°C in buffer A adjusted to 100 mM KCl
(two 10-min washes) and then in buffer A adjusted to 200 mM
KCl (one 10-min wash). Filters were autoradiographed, the
area of the filter corresponding to bound DNA was excised,
and the DNA was eluted by heating at 100°C in water. Eluted
DNA was amplified by 30 cycles of PCR with forward and
backward primers and purified on 2% agarose gels. For
subsequent rounds of binding, the 76-bp product was labeled
by 18 cycles of PCR in the presence of 32P-labeled nucleotide,
as described previously (33). DNA from the fifth round of
selection which remained bound to L2 after washing in buffer
A was eluted and amplified as described above, cloned into
pUC18, and sequenced.
Immuno-DNA binding assay. Extracts from HPV16L2 rVV-
infected cells were prepared and immunoprecipitated as de-
scribed above. Immune complexes attached to protein A-
Sepharose beads were incubated with BamHI-PstI-digested
HPV16 DNA for 2 h at 4°C in DNA-binding buffer (10 mM
Tris [pH 7.4], 100 mM NaCl, 1 mM MgCl2, 1 mM EDTA, 8%
glycerol, 1 mM DTT, 5% skim milk). Following incubation, the
beads were washed five times with the same buffer at room
temperature. Protein-DNA complexes were eluted in 1%
SDS-5 mM EDTA at 65°C. DNA was extracted with phenol
twice and precipitated with ethanol. Samples were run on a
1.5% agarose gel and blotted onto nylon membranes. The
DNA bound to the membranes was detected by Southern
blotting with 32P-labeled HPV16 DNA digested with PstI-
BamHI.
DNA sequencing. Dideoxy DNA sequencing was performed
with the Sequenase version 2.0 kit (U.S. Biochemicals, Cleve-
land, Ohio). To denature double-stranded DNA for sequenc-
ing, we incubated 2 ,ug of DNA for 30 min at 37°C in 200 mM
sodium hydroxide. DNA was ethanol precipitated, and se-
quencing carried out as specified by the manufacturer.
RESULTS
HPV16L2 protein binds DNA. To investigate the DNA-
binding activity of PV structural proteins, we expressed
HPV16L1 or HPV16L2 in eukaryotic cells by using rVV. Li
and L2 proteins were purified from cell lysates by immunopre-
cipitation, separated by SDS-PAGE (10% polyacrylamide),
and transferred to nitrocellulose filters. Binding of these
proteins to DNA was investigated by Southwestern blotting
with 32P-labeled PV genomic DNA and bacteriophage X DNA
in a buffer containing 40 mM NaCl. HPV16L2 protein bound
both HPV genomic DNA and X DNA (Fig. 1B, lanes 2 to 5).
HPV16L1 protein, in contrast, failed to bind any labeled DNA
(Fig. 1A, lanes 2 to 5), although the purified LI protein was
detectable on the filters by using an anti-HPV16L1 monoclonal
antibody (Fig. 1A lanes 1 and 6). Further experiments in
buffers containing up to 150 mM NaCl showed no binding of
DNA to HPV16L1 (data not shown). These results suggest
that HPV16L2 protein, but not HPV16L1 protein, contains
DNA-binding sequences and that the recognition of DNA by
HPV16L2 may not be sequence specific.
HPV16L2 N terminus is important for DNA binding. To
identify the protein sequence responsible for binding of L2 to
DNA, we first checked for DNA-binding motifs in the pre-
dicted amino acid sequence of HPV16L2. HPV16L2 has two
highly charged regions, rich in lysine and arginine. The first
makes up the N terminus of the protein (MRHKRSAKRTKR)
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FIG. 1. Characterization of HPV16LI (A) and HPV16L2 (B)
DNA-binding activity. HPV16L1 and HPV16L2 proteins, from rVV-
infected CV-1 cells, were immunoprecipitated by Li- or L2-specific
antibodies, separated by SDS-PAGE, and transferred to nitrocellulose.
Proteins were renatured in blocking buffer containing DTT and
incubated with 32P-labeled DNA from HPV16 (lane 2), HPV6b (lane
3), HPV11 (lane 4), or phage A (lane 5). Lane C is the immunopre-
cipitate from wild-type VV-infected cells. Unbound DNA was re-
moved, and DNA-binding proteins were detected by autoradiography.
The positions of the Li and L2 proteins, determined by immunoblot-
ting, are shown (lanes 1 and 6).
from amino acids 1 to 12; the second lies within the C terminus
(RKRRKR) from amino acids 456 to 461.
To determine whether either charged region was involved in
DNA binding to L2, we made a series of deletion mutants with
mutations in HPV16L2. Constructs encoding various C-termi-
nal or N-terminal mutations of HPV16L2 protein were in-
serted into plasmid pSX3, which had been previously shown to
efficiently direct the synthesis of the HPV16L1 proteins in
rVVs (36). CV-1 cells were infected with rVV containing each
mutant L2 gene, and cell lysate was analyzed by immunopre-
cipitation with a rabbit anti-HPV16L2 antibody. The expected
relative size of each mutated protein was confirmed by com-
paring the electrophoretic mobility of truncated proteins with
wild-type L2 protein (data not shown).
The deletion mutants were examined for binding to 32p-
labeled HPV16 genomic DNA by the Southwestern procedure
under conditions associated with binding of native L2 protein.
All C-terminal deletion mutants tested, including A374, which
had the longest deletion, bound HPV DNA in proportion to
the amount of immunoreactive L2 protein present (Fig. 2, lane
A374). To delineate the contribution of the N terminus of L2
to DNA binding, we constructed N-terminal deletion mutants
of L2. Three mutants, in which the first 60, 80, and 100 amino
acids of L2 were deleted, each failed to bind HPV DNA (Fig.
2, lanes A1-60 through A1-100). To further characterize the
N-terminal DNA-binding region, we tested a series of smaller
deletions between amino acids 1 and 15 for their DNA-binding
activity. Each of these, including the smallest deletion (which
was missing only the arginine residue at position 2), failed to
bind DNA (Fig. 3A, lanes A1-2 to Al-15). These results
suggested that critical DNA-binding sequences were in the N
terminus of L2 and that binding was dependent on charged
amino acids including the arginine at position 2.
L2 protein uses an arginine-rich motif for DNA binding.
The amino acid sequence of the N terminus of HPV16L2,
starting from position 1, is MRHKRSAKRTKR (one-letter
code with charged amino acids underlined). The role of the N
terminus of L2 protein in DNA binding was further assessed by
site-specific mutagenesis. Ten substitution mutants with muta-
tions of the first 9 amino acids were expressed by rVV, and
their DNA-binding activities were examined by Southwestern
blotting with 32P-labeled HPV16 genomic DNA. Similar
B
FIG. 2. Definition of the HPV16L2 DNA-binding region. L2 pro-
teins were separated by SDS-PAGE, transferred to a nitrocellulose
filter, and probed with 32P-labeled HPV16 DNA (A) or L2-specific
antiserum (B). C-terminal amino acid deletions are designated as
follows: amino acids 374 to 474 as A374, 384 to 474 as A384, 394 to 474
as A394, 404 to 474 as A404, and 414 to 474 as A414. Removal of amino
acids up to 100 from the C-terminal end had no effect on DNA
binding. N-terminal amino acid deletions were designated as follows:
amino acids I to 60 as A1-60, 1 to 80 as Al-80, and I to 100 as Al-100.
Removal of any N-terminal sequence diminished DNA binding mark-
edly. The L2 bands are indicated by arrows.
amounts of the various mutant L2 proteins constructed were
available for DNA binding, as determined by analysis of
immunoreactive L2 protein on the blots, with the exception of
K8P (Fig. 3B, lower panel). Mutation of some charged amino
acid residues (Lys-4, Lys-8, Arg-9) to Pro or Asn (K4P and
8,9N) abolished DNA binding (Fig. 3B, lanes K4P and 8,9N),
while substitution of Arg-5 with Pro (R5P) reduced binding
activity (lane R5P). In contrast, substitution of Arg-9 with Pro
(R9P) had no effect on DNA binding (lane R9P). Mutation of
the neutral amino acids between the Lys-Arg clusters had less
effect on DNA-binding activity. Mutations termed H3P, S6P,
and A7P, in which substitution of His-3, Ser-6, and Ala-7 for
Pro had been produced, showed binding of DNA comparable
to that with wild-type L2 (lanes H3P, S6P, and A7P); in
contrast, changing Ser-6 to Asn (S6N) abolished DNA binding
(lane S6N). These results suggest that the four charged amino
acid clusters are important for DNA binding. In each of these
charged amino acid clusters, retention of at least one charged
amino acid appears necessary for DNA binding. A flexible
secondary structure might also be important for L2-DNA
interaction because substitution of Ser-6 with Pro and of Arg-5
and Arg-9 did not abolish the DNA binding, whereas the
substitution of Ser-6 with Asn removed the L2 DNA-binding
function. A summary of L2-DNA interaction results is given in
Fig. 4.
L2-DNA interaction has no DNA sequence specificity. We
used a library of oligonucleotides and bound these to purified
HPV16L2 protein to select for any high-affinity target DNA
sequences. The oligonucleotides were random at 26 positions
and were flanked by primer and cloning sequences. After
incubation of L2 with a pool of these oligonucleotides, oligo-
nucleotides bound to L2 protein were eluted and amplified by
PCR for subsequent rounds of selection. Selection and ampli-
fication were carried out six times. DNA clones recovered after
the selection rounds 5 and 6 were sequenced. Probability
theory predicts that among 52 random 26-mer sequences, any
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FIG. 3. HPV DNA L2 protein interactions defined by using mu-
tants with L2 N-terminal mutations. (A) N terminus-truncated L2
proteins, with deletions indicated above each lane, were separated by
SDS-PAGE, transferred to nitrocellulose membranes, and incubated
with 32P-labeled HPV16 DNA (upper panel). The 32P-labeled DNA
was removed, and the filter was reprobed with a rabbit anti-HPV16L2
antibody for quantitation of the L2 protein (lower panel). L2 bands are
indicated by arrows, and molecular mass markers are indicated on the
left. (B) Substitution mutants of L2 proteins, as indicated above each
lane, were incubated with 32P-labeled HPV16 genomic DNA (upper
panel) or with rabbit anti-HPV16L2 antiserum (lower panel). L2 bands
are indicated by arrows, and the molecular mass markers are shown on
the left. Substitutions are coded as follows: WT, wild-type VV; H3P,
His-3 to Pro; K4P, Lys-4 to Pro; 2,4,5N, Arg-2 to Asn, Lys-4 to Asn,
Arg-5 to Asn; R5P, Arg-5 to Pro; S6N, Ser-6 to Asn; S6P, Ser-6 to Pro;
A7P, Ala-7 to Pro; K8P, Lys-8 to Pro; R9P, Arg-9 to Pro; 8,9N, Lys-8
to Asn, Arg-9 to Asn.
trinucleotide would be found in 20 clones (95% confidence
interval, 15 to 26) and any specificed sequence of 4 nucleotides
would be found in 5 of the 26-mers (95% confidence interval,
0 to 9). Among 52 26-mer clones we observed that the most
commonly observed trinucleotide (GGG) was present in 24
clones (twice in 5, three times in 1), whereas the most common
series of 4 bp (GGGG) was observed in 8 clones. Thus there
was no evidence that any short nucleotide sequence was
represented among these clones more frequently than would
be expected by chance alone. Further, no more complex
conserved nucleotide patterns were observed by using standard
sequence alignment programs. These results suggested that
high-affinity binding between L2 and DNA is a DNA sequence-
independent process. Two additional experiments confirmed
this observation. First, extract from cells infected with
DNA binding
HPV1 6L2
A2 ----------------------------
A15 _--____--_--_
R2P -P----------------------------
H3P --P---------------------------
K4P ---P--------------
2,4,5N -N-NN-------------------------
R5P ----P-------------------------
S6N -----N------------------------
S6P P-
A7P ------P-_--_--------_-__-_
K8P P-
R9P --------P---_--- __- __-_
+
+
+
+
+
8,9N -------NN--------------------- -
6,10N --N---N-------------------- -
11,12N ----------NN------------------ -
6,10,14N -----N---N---N---------------- -
FIG. 4. Binding of mutant L2 proteins to HPV DNA. For each
mutant, the sequence of the protein is given (single-letter code, with
conserved amino acids shown as dashes) and the binding of DNA to
the protein by Southwestern blot analysis is indicated (+ or
-).
HPV16L2 rVV was immunoprecipitated with anti-L2 anti-
body, and the precipitated protein-antibody complexes, at-
tached to Sepharose beads, were allowed to bind to a mixture
of restriction fragments from HPV16 genomic DNA. After
unbound DNA was washed away, bound DNA fragments were
resolved on a agarose gel and detected by Southern blotting
with 32P-labeled HPV16 DNA. An HPV16L2-containing ex-
tract, bound to Sepharose beads with anti-L2 antibody, re-
tained each of the HPV16 DNA fragments (Fig. 5, lanes 3, 6,
and 7), whereas none of these fragments were bound by an Li
rVV-infected cell extract bound to the bead with anti-Li
antibody (data not shown) or by wild-type VV-infected cell
extract bound to the beads with L2-specific antibodies (Fig. 5,
lane 22. Second, a fixed amount of L2 protein was incubated
with 3 P-labeled HPV DNA fragments, in the presence of a
100-fold (lane 4) or 1,000-fold (lane 5) excess of unlabeled X
DNA, and L2, together with any bound DNA, was immuno-
precipitated from the mixture by antibody to L2. Phage K DNA
was able to prevent binding of HPV DNA. We conclude that
L2 does not interact with DNA in a DNA sequence-specific
manner by each of these criteria.
DISCUSSION
The predicted sequence of the carboxy terminus of the Li
and L2 proteins of all sequenced PVs includes several basic
amino acids. We demonstrated that the carboxy terminus of
the Li protein of HPV16, which conforms to consensus
nuclear localization sequences defined for eukaryotic cells, is
necessary for nuclear localization of this protein (36). A basic
sequence is also found at the amino terminus of L2, but this
does not conform to the nuclear localization sequence motif
and resembles the arginine-rich region which has been associ-
ated with protein-RNA binding (19). An arginine-rich motif
sequence has previously been detected in several prokaryotic
and eukaryotic RNA-binding proteins (19, 20), and the VP1
J. VIROL.
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FIG. 5. DNA-binding assay for HPV16L2 proteins from rVVs. L2
protein was immunoprecipitated with anti-L2 antibody. Equal
amounts of L2 protein were incubated with PstI-BamHI-cleaved
HPV16 genomic DNA. The bound DNA fragments were eluted with
1% SDS and subjected to Southern blotting with 32P-labeled HPV16
DNA (lanes 3, 6, and 7). In some experiments, a 100-fold (lane 4) or
1,000-fold (lane 5) molar excess of phage X DNA was added to the
initial incubation of HPV DNA with L2 protein. Mock assay of a
control precipitate from wild-type VV-infected cells is also shown
(lane 2). On the left the input DNA fragments are labeled from A to
G. A linearized map of the HPV16 DNA is shown below. Restriction
sites are PstI (p) and BamHI (b), and the corresponding fragments are
labeled A to G according to size.
protein of polyomavirus has been shown to interact with DNA
in a nonspecific fashion by using a similar sequence (26). Our
data show that the arginine-rich region at the amino terminus
of the L2 protein of HPV16 is critical for the binding of L2 to
nucleic acid. The basic amino acid sequence at the carboxy
terminus of L2 did not contribute to protein-DNA interaction
and may, like its counterpart in LI, function as a nuclear
localization sequence. The LI protein of HPV16 did not bind
DNA in our system. Polyomavirus uses the major structural
protein for DNA interaction, and the minor (VP2 and VP3)
proteins of polyomavirus do not seem to interact with DNA;
however, other members of the family Papovaviridiae, like
HPV16, interact with DNA via their minor capsid proteins and
have similar basic amino-terminal sequences (8).
Our results suggest that DNA binding to L2 requires mul-
tiple basic amino acid sequences working in concert, while the
amino acids separating the basic residues also contribute to
DNA-binding activity. Similarities between the amino-terminal
sequences of PV L2 proteins were identified in searches of the
GenBank and EMBL data bases. The basic residues (Arg
and/or Lys) are in each case located proximally in the amino-
terminal sequence of L2, and their side chains could be
positioned so that their positive charges interact with the
backbone phosphates of the DNA helix.
To study the intrinsic DNA-binding activity of LI and L2
proteins, it was necessary to exclude the contribution of
cellular proteins to this reaction. We therefore examined
binding of HPV DNA, produced in a prokaryotic system, to
viral proteins isolated by immunoprecipitation and separated
by SDS-PAGE for Southwestern analysis, because this avoided
exposure of the HPV DNA to cellular proteins including
histones. HPV16L2 protein associated with DNA under our
assay conditions, whereas HPV16L1 protein did not. This
latter observation is in contrast with previous work (22), which
showed that prokaryotic L2 bound DNA and also that a
prokaryotic N-terminally truncated LI fusion protein, with
37% of the sequence from the N terminus removed, had
DNA-binding activity. The LI or L2 protein of HPV16 pro-
duced by VV are nonfused proteins which should have correct
posttranslational modifications, including glycosylation (38)
and phosphorylation (35), which could affect DNA-binding
affinity (21, 32). Because the LI protein we used in this study
was a nonfusion protein expressed in eukaryotic cells, we
believe that this protein should have correct posttranslational
modifications. Further, the binding demonstrated in this assay
occurred under physiologic conditions of pH and salt concen-
tration. Thus, our LI-DNA-binding results are more likely to
be representative of events within epithelial cells infected with
HPV. However, the Southwestern assay system depends on
prior immobilization of the test viral protein to positively
charged nitrocellulose while the protein is denatured in SDS,
and this would favor the demonstration of amino- or carboxy-
terminal regions as DNA binding, so we cannot regard Ll-
DNA interactions under physiological conditions as excluded
by our results.
We have previously shown that the minor capsid protein
(L2) of HPV16 plays a role in the assembly of infectious PV
virions: whereas viruslike particles assemble if LI protein alone
is expressed in eukaryotic cells (17), expression of both LI and
L2 together are necessary for the assembly of infectious virions
(37), at least when the proteins are expressed by rVV in vitro.
The findings reported here suggest that one role of L2 in the
assembly of infectious PV virions may be to link the PV capsid
to the viral minichromosome, a function made necessary by a
lack of demonstrable interaction of HPV LI protein with HPV
DNA. Since one purpose of any virus capsid is to provide a
protective container for the viral genome, capsid proteins are
expected to exhibit some potential for direct (basic or other
polar amino acid side chains) or indirect (encapsidated poly-
amines) interaction with nucleic acid (5). This interaction may
be important in nucleation of capsid assembly but could also
serve a structural purpose in defining the viral architecture for
DNA viruses, as is now well recognized for RNA viruses, many
of which will assemble virions only in the presence of appro-
priate viral RNA (2, 5, 25).
Studies of RNA viruses have shown that specific encapsida-
tion initiation sites are present on the viral genome (3). Such
sites have also been identified for DNA viruses (27, 30). Our
data do not support the hypothesis that packaging selectivity in
PV could be achieved by sequence-specific recognition process
between viral structural proteins and PV DNA. Lack of specific
reactivity also makes a role for the L2-DNA interaction in
regulation of transcription, replication, recombination, or viral
integration less likely. This finding is perhaps not too surpris-
ing, because the expression of capsid proteins occurs in
terminally differentiated cells already programmed to undergo
apoptotic death.
A model has been proposed for the structure of polyomavi-
rus, which has an identical T=7d icosahedral structure to PV
(14). Polyomavirus VP1 protein, which has sequence homology
with HPVL1 and will similarly self-assemble into viruslike
particles, can interact with VP2 and VP3, which have homol-
ogies with PV L2, including an arginine-rich amino terminus.
Approximately one molecule of VP2 and VP3 is associated
with each VP1 pentamer, just as approximately one molecule
of L2 is associated with each LI pentamer in HPV. The crystal
structure of polyomavirus has been partially solved, but the
exact binding region of VP2 and VP3 with VP1 is unclear: it
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has been proposed that VP2 and VP3, which have DNA-
binding activity, facilitate correct and preferential assembly of
complete polyomavirus particles by preventing VP1 assembly
in the absence of DNA (8). Our data, taken together with this
model, suggest that the amino terminus of L2 will be located
deep within the viral particle in contact with the viral minichro-
mosome, which is supercoiled round cellular histone proteins.
The viral minichromosome will be held in place by an array of
L2 proteins, each interacting via its amino terminus with any
convenient stretch of viral DNA and, at a more carboxy
location, with a pentameric Li capsomere. In the terminally
differentiating PV-infected keratinocyte, HPV DNA would be
one of the most abundant short polynucleotides and nuclear
DNA would generally be present in the form of condensed
cellular chromatin (23). No specific protein-DNA interaction
may therefore be required for PV particle assembly. Alterna-
tively, Li protein (36a) appear to localize in particular areas of
the cell nucleus in the presence of L2 protein, at least in vitro.
If some mechanism exists for local concentration of Li, L2,
and viral DNA, correct viral assembly would follow. Use of L2
deletion mutants as described here should facilitate testing of
these alternate hypotheses.
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